Alan I. Leshner, (Chair), American Association for the Advancement of Science, Washington D.C.

Alan Breier, Eli Lilly and Company, Indianapolis, Indiana

David H. Cohen, Columbia University, New York, New York, and Society for Neuroscience representative

Richard J. Hodes, National Institute on Aging, Bethesda, Maryland

Steven E. Hyman, Harvard University, Cambridge, Massachusetts

Thomas R. Insel, National Institute of Mental Health, Bethesda, Maryland

Story C. Landis, National Institute on Neurological Disease and Stroke, Bethesda, Maryland

Ting-Kai Li, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland 

Michael Oberdorfer, NIH Blueprint for Neuroscience, Bethesda, Maryland

Kathie L. Olsen, National Science Foundation, Arlington, Virginia

William Z. Potter, Merck Research Laboratories, North Wales, Pennsylvania

Robert C. Richardson, Cornell University, New York

Paul. A. Sieving, National Eye Institute, Bethesda, Maryland

Rae Silver, Columbia University, New York

Roy E. Twyman, Johnson and Johnson Pharmaceutical Research and Development, Titusville, New Jersey

Nora D. Volkow, National Institute on Drug Abuse, Bethesda, Maryland